Page last updated: 2024-08-21

megestrol acetate and Breast Cancer

megestrol acetate has been researched along with Breast Cancer in 173 studies

Research

Studies (173)

Timeframe	Studies, this research(%)	All Research%
pre-1990	49 (28.32)	18.7374
1990's	81 (46.82)	18.2507
2000's	33 (19.08)	29.6817
2010's	10 (5.78)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Casazza, AM; Horwitz, SB; Trail, PA; Wang, L; Yang, CP	1
Bing, S; Lijuan, D; Santai, S; Shaohua, Z; Shikai, W; Tao, W; Xiangying, M; Xin, Z; Yan, M; Yue, W; Zefei, J	1
Bines, J; Branco, LGP; Camacho, PG; Castro, TM; Costa, MEF; Dienstmann, R; Obadia, RM; Quintella, DC; Soares, FA	1
Carlström, K; Fahlén, M; Löfgren, L; Naessén, S; Söderqvist, G; von Schoultz, E	1
Baby, T; Chennazhi, KP; Jayakumar, R; Rejinold, NS	1
Chang, YJ; Lai, SW; Lee, CW; Morisky, DE; Muo, CH; Wang, IK; Yang, SP	1
Batson, S; Jones, N; Livings, C; Telford, C	1
Ah-See, ML	1
Jonsson, H; Kemetli, L; Lenner, P; Nyström, L; Rutqvist, LE; Törnberg, S	1
Ali, SM; Demers, L; Evans, DB; Evans, M; Leitzel, K; Lipton, A; Vo, MN; Wilson, M	1
Lønning, PE	1
Alonso, A; Laenen, A	1
Carli, AF; Correale, P; Francini, E; Francini, G; Guarnieri, A; Licchetta, A; Magliocca, A; Migali, C; Pascucci, A; Piccolomini, A; Remondo, C; Savelli, V	1
Bergaglio, M; Bertelli, G; Biglia, N; Costantini, M; Del Mastro, L; Porcile, G; Pronzato, P; Rosso, R; Sismondi, P; Venturini, M; Venturini, S	1
Ali, SM; Allard, JW; Carney, W; Chinchilli, VM; Demers, L; Engle, L; Harvey, HA; Leitzel, K; Lipton, A	1
Sleijfer, DT; Wymenga, AN	1
Ceccherini, R; Dellach, C; Leita, ML; Milani, S; Muggia, M; Mustacchi, G	1
Burton, G; Kleeberg, U; Mauriac, L; Osborne, CK; Robertson, JF; Vergote, I	1
Parker, LM; Piccart, M; Pritchard, KI	1
Rose, C	1
Campos, SM	1
Carlström, K; Fornander, T; Löfgren, L; Rutqvist, LE; von Schoultz, B; von Schoultz, E; Wallberg, B; Wilking, N	1
Ingle, JN; Suman, VJ	1
Gorbunova, VA; Howell, A; Lichinitser, MR; Pienkowski, T; Robertson, JF; Watanabe, T	1
Pritchard, KI; Wong, NS	1
Cheung, KL; Owers, R; Robertson, JF	1
DiLeonardo, M; Gibbons, G; Resnik, KS	1
Ali, SM; Brown-Shimer, S; Carney, W; Demers, L; Evans, DB; Hamer, P; Leitzel, K; Lipton, A; Pierce, K	1
Fjøsne, HE; Jacobsen, AB; Lundgren, S	1
Albain, KS; Bearden, JD; Giguere, JK; Goodwin, JW; Green, SJ; Jiang, CS; Lippman, SM; Martino, S; Moinpour, CM	1
Carnero López, B; Carrasco Alvarez, JA; Fernández Pérez, I; Gentil González, M; González Villarroel, P; Páramo, C; Vázquez Tuñas, ML	1
Andersen, J; Cold, S; Ejlertsen, B; Ewertz, M; Jacobsen, EH; Jensen, D; Kamby, C; Møller, KA; Møller, S; Philip, P	1
Blumenschein, GR; Buzdar, AU; Ross, MB	1
Alexieva-Figusch, J; Blonk-van der Wijst, J; Hop, WC; Teulings, FA; van Gilse, HA	1
Blumenschein, GR	1
Canetta, R; Florentine, S; Hunter, H; Lenaz, L	1
Adlercreutz, H; Alexieva-Figusch, J; Blankenstein, MA; de Jong, FH; Docter, R; Hop, WC; Klijn, JG; Lamberts, SW; van Gilse, HA	1
Alexieva-Figusch, J; Blankenstein, MA; de Jong, FH; Lamberts, SW	1
Klijn, JG	1
Greenwald, ES	1
Ansfield, FJ; Kallas, GJ; Singson, JP	1
Archer, SG; Barnes, D; Blamey, RW; Eliopoulos, A; Ellis, IO; Nicholson, RI; Robertson, JF; Spandidos, D	1
Dahrouge, S; Stewart, DJ	1
Chinchilli, VM; Demers, L; Grossberg, H; Harvey, H; Konrad, K; Leitzel, K; Lipton, A; Teramoto, Y; Volas, G	1
Amoroso, D; Balestrero, M; Boccardo, F; Brema, F; Cellerino, R; Farris, A; Folco, U; Iacobelli, S; Mesiti, M; Miglietta, L	1
Fletcher, WS; Pommier, RF; Woltering, EA	1
Harrison-Woolrych, M; Robinson, R	1
Blamey, RW; Cannon, P; Ellis, IO; Gee, JM; Manning, DL; McClelland, RA; Nicholson, RI; Robertson, JF	1
Hill, LM; Lazebnik, N; Robinson, TM	1
Altaras, M; Beyth, Y; Cohen, I; Cordoba, M; Shulman, A; Tepper, R	1
Crawford, DJ; George, WD; Leake, RE; Paul, J; Smith, DC; Stewart, M	1
Espie, M	1
Dose, AM; Fischer, T; Hatfield, AK; Johnson, C; Klatt, NE; Loprinzi, CL; Michalak, JC; Nelimark, RA; O'Fallon, JR; Quella, SK	1
Beinfield, M; Fischer, D; Haffty, BG; McKhann, C; Wilmarth, L; Wilson, L	1
Abrams, J; Aisner, J; Canellos, GP; Cooper, MR; Herndon, JE; Hollis, DR; Kornblith, AB; Lyss, AP; Phillips, CA; Zuckerman, E	1
Burns, I; Byrne, M; Coates, A; Gebski, V; Gill, PG; Levi, J; Snyder, R	1
Cobau, CD; Declercq, K; Ingle, JN; Neuberg, D; Tormey, DC	1
Demers, L; Grossberg, H; Leitzel, K; Lipton, A; Teramoto, Y; Volas, GH	1
Azab, M; Blomqvist, C; Buzdar, A; Eiermann, W; Howell, A; Jonat, W; Jones, SE; Plourde, PV; Vogel, CL; Webster, A; Wolter, JM	1
Buzdar, AU; Hortobagyi, GN; Plourde, PV	1
Batist, G; Damian, S; Damian, Z; Georges, E; Jean-Claude, BJ; Leyland-Jones, B; Liu, Z; Mustafa, A; Panasci, L; Vasilescu, D	1
Blackledge, GR; Earl, H; Keen, C; Spooner, D; Stuart, NS; Taylor, AR; Tyrell, C; Warwick, J; Webster, DJ	1
Frost, VJ; Helle, SI; Holly, JM; Lønning, PE; van der Stappen, JW	1
Buzdar, AU; Jones, SE; Plourde, P; Vogel, CL; Webster, A; Wolter, J	1
Votaw, ML	1
Goker, H; Kanji, A; Subramanian, S; Sweeney, H	1
Bonnefoi, H; Castiglione, M; Cavalli, F; Fey, MF; Goldhirsch, A; Hsu-Schmitz, SF; Löhnert, T; Morant, R; Thürlimann, B	1
Rubens, RD	1
Blamey, RW; Cheung, KL; Ellis, IO; Elston, CW; Nicholson, RI; Pinder, SE; Robertson, JF; Willsher, PC	1
Fried, G; Haim, N; Stein, M	1
Jonat, W	1
Hyder, SM; Murthy, L; Stancel, GM	1
Bellmunt, J; Bezwoda, W; Chaudri, HA; Dombernowsky, P; Falkson, G; Fornasiero, A; Gardin, G; Gudgeon, A; Hatschek, T; Hoffmann, W; Hornberger, U; Leonard, R; Michel, J; Morgan, M; Panasci, L; Smith, I; Tjabbes, T; Trunet, PF	1
Bamberger, AM; Schulte, HM; Thuneke, I	1
Harvey, HA	1
Smith, IE	1
DeKrey, WL; Finck, G; Fischer, T; Loprinzi, CL; Pierson, N; Pisansky, T; Quella, SK; Sloan, JA; Vaught, NL	1
Vyzula, R	1
Berstein, LM	1
Diamandis, EP	1
Helle, SI; Lonning, PE; Lundgren, S	1
Baider, L; Barak, V; Farbstein, H; Fridlender, ZG; Kalickman, I; Kaplan, A; Nisman, B; Peretz, T; Stephanos, S	1
Diamandis, EP; Helle, SI; Lonning, PE; Lundgren, S; Melegos, DN; Yu, H	1
Agelaki, S; Chalkiadakis, G; Georgoulias, V; Kakolyris, S; Kalbakis, K; Koukourakis, M; Samonis, G; Sanidas, E; Tsiftsis, D; Vlachonicolis, J	1
Goss, PE; Schwartz, LH; Tannock, IF; Winer, EP	1
Abrams, J; Aisner, J; Berry, DA; Cirrincione, C; Cooper, MR; Ellerton, J; Henderson, IC; Kirshner, J; Muss, HB; Norton, L; Panasci, L	1
Blijham, GH; de Jong, PC	1
Benson, S; Cella, D; Fallowfield, LJ; Howell, A; Leaity, SK	1
Dewar, JA; Leese, GP; Naing, KK	1
Ekse, D; Geisler, S; Helle, SI; Holly, JM; Lundgren, S; Lønning, PE	1
Bernhard, J; Bonnefoi, H; Castiglione-Gertsch, M; Cavalli, F; Fey, MF; Goldhirsch, A; Hürny, C; Morant, R; Schmitz, SF; Thürlimann, B	2
Chaudri, HA; Trunet, PF	1
Bland, KI; Buzdar, AU	1
Bland, KI	1
Buzdar, A; Howell, A; Lee, D; Robertson, JF; von Euler, M	1
Arkhipov, A; Bajetta, E; Cervek, J; di Salle, E; Dirix, LY; Dugardyn, JL; Fein, LE; Fowst, C; Jones, SE; Kaufmann, M; Massimini, G; Mennel, RG; Miller, LL; Nasurdi, C; Piscitelli, G; Polli, A; Zilembo, N	2
Dranitsaris, G; Leung, P; Mather, J; Oza, A	1
Bajetta, E; Cervek, J; Di Salle, E; Dirix, LY; Fein, LE; Fowst, C; Jones, SE; Kaufmann, M; Massimini, G; Piscitelli, G; Polli, A	1
Howell, A	1
Bonte, J	1
Brady, C; Buzdar, A; Davidson, N; Douma, J; Elledge, R; Morgan, M; Nabholtz, J; Porter, L; Smith, R; Xiang, X	1
Hoffmann, O; Oberhoff, C; Schindler, AE; Winkler, UH	1
Joy, AA; Mackey, JR	1
Gebski, V; Hudson, HM; Lumley, T; Simes, RJ	1
Buzdar, AU	1
Ingle, JN	1
Cruz, JM; Muss, HB	1
Abrams, JS; Aisner, J; Gutheil, J	1
Cruz, JM; Muss, HB; Russell, G	1
Blamey, RW; Chan, S; Dixon, AR; Haybittle, J; Jackson, L	1
Bates, K; Blamey, RW; Nicholson, RI; Pearson, D; Robertson, JF	1
Larsen, M; Pors, H; Sørensen, OS; von Eyben, FE	1
Daniel, F; Rao, DG; Tyrrell, CJ	1
Brenner, BG; Margolese, RG	1
Amoroso, D; Bertelli, G; Brema, F; Conte, PF; Martini, MC; Pastorino, G; Pronzato, P; Rosso, R	1
Blamey, RW; Griffiths, K; Pearson, D; Turkes, A; Williams, MR	2
Sleijfer, DT; Tjabbes, T; van der Ploeg, E; van Veelen, H; Willemse, PH	1
Dikkeschei, LD; Sleijfer, DT; Tjabbes, T; van Veelen, H; Willemse, PH	1
Lundgren, S; Lønning, PE	1
Aisner, J; Greco, A; Hickman, M; Siau, J; Tchekmedyian, NS	1
de Ruyter-Buitenhuis, AW; Dikkeschei, LD; Nagel, GT; Sleijfer, DT; van der Slik, W; Willemse, PH; Wolthers, BG	1
Canetta, R; Kelley, S; Nicaise, C; Rozencweig, M; Schacter, LP; Smaldone, L	1
Abrams, JS; Aisner, J; Parnes, H	1
Alexieva-Figusch, J; Stoter, G; van der Gaast, A; Vecht, C; Verweij, J	1
Capizzi, RL; Case, LD; Cooper, MR; Cruz, J; Jackson, D; Muss, HB; Powell, BL; Richards, F; Spurr, CL; White, D	1
Aakvaag, A; Kvinnsland, S; Lundgren, S; Lønning, PE	1
Anderson, S; Sigal, RB; Smalley, RV	1
Dahrouge, S; Fine, S; Hanson, J; McDermot, RS; Paterson, AH; Pritchard, KI; Sansregret, E; Stewart, DJ; Trudeau, M; White, DF	1
Brockschmidt, JK; Cruz, JM; Evans, GW; Muss, HB	1
Aakvaag, A; Kvinnsland, S; Lundgren, S; Lønning, PE; Utaaker, E	1
Canetta, R; Kelley, S; Nicaise, C; Rozencweig, M; Schacter, L; Smaldone, L	1
Kvinnsland, S; Lundgren, S; Utaaker, E	1
Blamey, RW; Morgan, DA; Nicholson, RI; Robertson, JF; Todd, J; Williams, MR	1
Carpenter, JT	1
Foitl, DR; Hyman, G; Lefkowitch, JH	1
Blackledge, GR; Latief, T; Morrison, M; Mould, JJ; Spooner, D	1
Bakke, O; Kvinnsland, S; Lundgren, S; Ueland, PM; Utaaker, E	1
Bönisch, E; Gärtner, E; Hartlapp, J; Kleeberg, UR; Nagel, GA; Scherpe, A; Wander, HE	1
Becher, R; Miller, AA; Schmidt, CG	1
Kvinnsland, S; Lönning, PE; Lundgren, S; Wiedemann, G	1
Blossey, HC; Emrich, D; Nagel, GA; Wander, HE	1
Glick, JH; Haller, DG	1
Allegra, J; Bertino, JR; Bonomi, P; Browder, H; Byrne, P; Carpenter, J; Catalano, R; Creech, R; Dana, B; Ettinger, DS	1
Blamey, RW; Griffiths, K; Pearson, D; Turkes, A; Twining, P; Williams, MR	1
Sedlacek, SM	1
Aisner, J; Novak, M; Parnes, H; Tait, N; Tchekmedyian, NS	1
Black, WR; Capizzi, RL; Christian, R; Cooper, MR; Cruz, JM; Jackson, DV; Muss, HB; Paschold, EH; Powell, BL; Wells, HB	1
Anderson, K; Bonomi, P; Economou, S; Gale, M; Johnson, P; Von Roenn, J; Wolter, J	1
Black, W; Bonomi, P; Cooper, M; Johnson, PA; Muss, H; Paschold, E; Von Roenn, J; Wolter, J	1
Anderson, KM; Bonomi, PD; Economou, SG; Gale, M; Von Roenn, JH; Wolter, JM	1
Abrams, J; Aisner, J; Tait, N; Tchekmedyian, NS	1
Alexieva-Figusch, J; Schrijver, J; van Breederode, N; van Gilse, HA	1
Gale, KE; Hahn, RG; Horton, J; Keller, AM; Knuiman, M; Rosenbluth, RJ; Tormey, DC; Vogel, H	1
Aisner, J; Moody, M; Tait, N; Tchekmedyian, NS	2
Allegra, JC	1
Aisner, J; Tait, N; Tchekmedyian, NS	1
Anderson, KM; Bonomi, PD; Economou, SG; Johnson, PA; Wolter, JM	1
Aisner, J; Greco, FA; Moody, M; Tait, N; Tchekmedyian, NS	1
Cohen, SC; Gregory, EJ; Mims, CH; Oines, DW	1
Black, WR; Capizzi, RL; Christian, R; Cooper, MR; Cruz, JM; Jackson, DV; Muss, HB; Paschold, EH; Richards, F; Stuart, JJ	1
Allegra, JC; Bertino, J; Bonomi, P; Byrne, P; Carpenter, J; Catalano, R; Creech, R; Dana, B; Durivage, H; Einhorn, L	1
Blankenstein, MA; de Jong, FH; Klijn, JG; Lamberts, SW	1
Benghiat, A; Cassidy, SA; Davidson, HE; Mancero, FS; Pickard, JG; Tyrrell, CJ	1
Allegra, JC; Kiefer, SM	1
Carpenter, JT; Peterson, L	1
Morgan, LR	1
Anderson, K; Bonomi, P; Bunting, N; Economou, S; Johnson, P; Roseman, D; Shorey, W; Strauss, A; Wolter, J	1
Alexieva-Figusch, J; Blonk-vd Wijst, J; Klijn, JG; van Gilse, HA; Van Putten, WL	1

Reviews

24 review(s) available for megestrol acetate and Breast Cancer

Article	Year
Network Meta-Analysis Comparing Overall Survival for Fulvestrant 500 mg Versus Alternative Therapies for Treatment of Postmenopausal, Estrogen Receptor-Positive Advanced Breast Cancer Following Failure on Prior Endocrine Therapy. Clinical breast cancer, 2016, Volume: 16, Issue:3 Topics: Anastrozole; Androstadienes; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Disease-Free Survival; Dose-Response Relationship, Drug; Estradiol; Everolimus; Female; Fulvestrant; Humans; Letrozole; Megestrol Acetate; Network Meta-Analysis; Nitriles; Postmenopause; Receptors, Estrogen; Treatment Outcome; Triazoles	2016
Additive endocrine therapy for advanced breast cancer - back to the future. Acta oncologica (Stockholm, Sweden), 2009, Volume: 48, Issue:8 Topics: Androgens; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Drug Resistance, Neoplasm; Estrogen Receptor Modulators; Estrogens; Female; Humans; Megestrol Acetate; Progestins; Receptors, Estrogen	2009
Management of hot flushes in breast cancer patients. Acta oncologica (Stockholm, Sweden), 2002, Volume: 41, Issue:3 Topics: Adrenergic alpha-Agonists; Breast Neoplasms; Cyclohexanols; Female; Hot Flashes; Humans; Megestrol Acetate; Venlafaxine Hydrochloride	2002
Oestrogen receptor downregulation: an opportunity for extending the window of endocrine therapy in advanced breast cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 2003, Volume: 14, Issue:7 Topics: Aged; Aromatase Inhibitors; Breast Neoplasms; Down-Regulation; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Megestrol Acetate; Middle Aged; Postmenopause; Prognosis; Quality of Life; Receptors, Estrogen; Tamoxifen	2003
A comparison of the efficacy of aromatase inhibitors in second-line treatment of metastatic breast cancer. American journal of clinical oncology, 2003, Volume: 26, Issue:4 Topics: Aminoglutethimide; Anastrozole; Androstadienes; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Enzyme Inhibitors; Female; Humans; Letrozole; Megestrol Acetate; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Receptors, Estrogen; Tamoxifen; Triazoles	2003
Aromatase inhibitors for breast cancer in postmenopausal women. The oncologist, 2004, Volume: 9, Issue:2 Topics: Anastrozole; Androstadienes; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Enzyme Inhibitors; Female; Humans; Letrozole; Megestrol Acetate; Nitriles; Postmenopause; Receptors, Estrogen; Tamoxifen; Triazoles	2004
Aromatase inhibitors for therapy of advanced breast cancer. The Journal of steroid biochemistry and molecular biology, 2005, Volume: 95, Issue:1-5 Topics: Anastrozole; Androstadienes; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials, Phase III as Topic; Drug Evaluation; Female; Humans; Letrozole; Megestrol Acetate; Nitriles; Postmenopause; Tamoxifen; Treatment Outcome; Triazoles	2005
A review of exemestane in the management of breast cancer. Expert opinion on pharmacotherapy, 2005, Volume: 6, Issue:13 Topics: Administration, Oral; Androstadienes; Animals; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Megestrol Acetate; Multicenter Studies as Topic; Neoadjuvant Therapy; Randomized Controlled Trials as Topic; Tamoxifen; Treatment Outcome	2005
Megestrol acetate. Cancer treatment reviews, 1983, Volume: 10, Issue:3 Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Drug Evaluation, Preclinical; Female; Humans; Kidney Neoplasms; Kinetics; Male; Megestrol; Megestrol Acetate; Prostatic Neoplasms; Uterine Neoplasms	1983
Clinical overview of anastrozole--a new selective oral aromatase inhibitor. Oncology, 1997, Volume: 54 Suppl 2 Topics: Administration, Oral; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Female; Humans; Megestrol Acetate; Nitriles; Postmenopause; Prospective Studies; Randomized Controlled Trials as Topic; Treatment Outcome; Triazoles	1997
Emerging role of aromatase inhibitors in the treatment of breast cancer. Oncology (Williston Park, N.Y.), 1998, Volume: 12, Issue:3 Suppl 5 Topics: Aged; Aminoglutethimide; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Estrogens; Female; Humans; Letrozole; Megestrol Acetate; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Randomized Controlled Trials as Topic; Triazoles	1998
Pivotal trials of letrozole: a new aromatase inhibitor. Oncology (Williston Park, N.Y.), 1998, Volume: 12, Issue:3 Suppl 5 Topics: Aminoglutethimide; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Disease-Free Survival; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Humans; Letrozole; Megestrol Acetate; Nitriles; Treatment Outcome; Triazoles	1998
[Current views on use of megestrol acetate in oncology practice]. Vnitrni lekarstvi, 1997, Volume: 43, Issue:4 Topics: Antineoplastic Agents, Hormonal; Appetite Stimulants; Breast Neoplasms; Cachexia; Female; Humans; Megestrol Acetate; Neoplasms	1997
[Megestrol acetate as hormone therapy in oncology]. Voprosy onkologii, 1998, Volume: 44, Issue:2 Topics: Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Humans; Medroxyprogesterone; Megestrol Acetate; Neoplasms, Hormone-Dependent; Progesterone Congeners; Tamoxifen	1998
New aromatase inhibitors for the treatment of advanced breast cancer in postmenopausal women. The Netherlands journal of medicine, 1999, Volume: 55, Issue:2 Topics: Aminoglutethimide; Anastrozole; Androstadienes; Androstenedione; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Female; Humans; Letrozole; Megestrol Acetate; Nitriles; Postmenopause; Triazoles	1999
Third generation aromatase inhibitors in metastatic breast cancer patients failing tamoxifen. Randomized comparisons with megestrol acetate: a critical review. European journal of gynaecological oncology, 2000, Volume: 21, Issue:6 Topics: Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Estrogen Antagonists; Female; Humans; Megestrol Acetate; Neoplasms, Hormone-Dependent; Randomized Controlled Trials as Topic; Tamoxifen; Treatment Failure; Treatment Outcome	2000
A summary of second-line randomized studies of aromatase inhibitors. The Journal of steroid biochemistry and molecular biology, 2001, Volume: 79, Issue:1-5 Topics: Aminoglutethimide; Anastrozole; Androstadienes; Aromatase Inhibitors; Breast Neoplasms; Drug Tolerance; Enzyme Inhibitors; Estrogen Receptor Modulators; Fadrozole; Female; Humans; Letrozole; Megestrol Acetate; Neoplasms, Hormone-Dependent; Nitriles; Randomized Controlled Trials as Topic; Tamoxifen; Triazoles	2001
High-dose progestin therapy for metastatic breast cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 1992, Volume: 3 Suppl 3 Topics: Breast Neoplasms; Female; Humans; Medroxyprogesterone; Megestrol; Megestrol Acetate; Neoplasm Metastasis	1992
Overview of hormonal therapy in advanced breast cancer. Seminars in oncology, 1990, Volume: 17, Issue:6 Suppl 9 Topics: Breast Neoplasms; Female; Humans; Male; Megestrol; Megestrol Acetate; Meta-Analysis as Topic; Tamoxifen	1990
Current status of high-dose progestins in breast cancer. Seminars in oncology, 1990, Volume: 17, Issue:6 Suppl 9 Topics: Antineoplastic Agents; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Progesterone Congeners	1990
Megestrol acetate: clinical experience. Cancer treatment reviews, 1989, Volume: 16, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Adult; Animals; Anorexia; Breast Neoplasms; Cachexia; Carcinoma, Renal Cell; Contraceptive Agents, Male; Contraceptives, Oral; Endometrial Hyperplasia; Female; Humans; Kidney Neoplasms; Male; Megestrol; Megestrol Acetate; Melanoma; Middle Aged; Ovarian Neoplasms; Prostatic Hyperplasia; Prostatic Neoplasms; Rabbits; Tamoxifen; Uterine Neoplasms	1989
Progestational agents in the treatment of breast cancer. Cancer treatment and research, 1988, Volume: 39 Topics: Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Norethindrone; Norethindrone Acetate; Progestins	1988
An overview of megestrol acetate for the treatment of advanced breast cancer. Seminars in oncology, 1988, Volume: 15, Issue:2 Suppl 1 Topics: Breast Neoplasms; Combined Modality Therapy; Female; Humans; Megestrol; Megestrol Acetate; Menopause; National Institutes of Health (U.S.); Tamoxifen; United States	1988
Studies of high-dose megestrol acetate: potential applications in cachexia. Seminars in oncology, 1988, Volume: 15, Issue:2 Suppl 1 Topics: Body Weight; Breast Neoplasms; Cachexia; Drug Evaluation; Female; Humans; Megestrol; Megestrol Acetate	1988

Trials

63 trial(s) available for megestrol acetate and Breast Cancer

Article	Year
Activity of megestrol acetate in postmenopausal women with advanced breast cancer after nonsteroidal aromatase inhibitor failure: a phase II trial. Annals of oncology : official journal of the European Society for Medical Oncology, 2014, Volume: 25, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Aromatase Inhibitors; Breast Neoplasms; Disease-Free Survival; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Megestrol Acetate; Middle Aged; Neoplasm Staging; Neoplasms, Hormone-Dependent; Postmenopause	2014
Elevated plasma endoglin (CD105) predicts decreased response and survival in a metastatic breast cancer trial of hormone therapy. Breast cancer research and treatment, 2010, Volume: 119, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antigens, CD; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Breast Neoplasms; Double-Blind Method; Drug Resistance, Neoplasm; Endoglin; Enzyme-Linked Immunosorbent Assay; Fadrozole; Female; Humans; Kaplan-Meier Estimate; Megestrol Acetate; Middle Aged; Receptors, Cell Surface	2010
Oral metronomic chemo-hormonal-therapy of metastatic breast cancer with cyclophosphamide and megestrol acetate. Journal of chemotherapy (Florence, Italy), 2010, Volume: 22, Issue:3 Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cyclophosphamide; Female; Humans; Liver Neoplasms; Lung Neoplasms; Megestrol Acetate; Middle Aged; Neoplasm Staging; Survival Rate; Treatment Outcome	2010
Intramuscular depot medroxyprogesterone versus oral megestrol for the control of postmenopausal hot flashes in breast cancer patients: a randomized study. Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13, Issue:6 Topics: Administration, Oral; Aged; Breast Neoplasms; Chi-Square Distribution; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Hot Flashes; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Megestrol Acetate; Middle Aged; Patient Satisfaction; Postmenopause; Probability; Reference Values; Severity of Illness Index; Treatment Outcome	2002
Relationship of serum HER-2/neu and serum CA 15-3 in patients with metastatic breast cancer. Clinical chemistry, 2002, Volume: 48, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Breast Neoplasms; Double-Blind Method; Fadrozole; Female; Humans; Megestrol Acetate; Middle Aged; Mucin-1; Neoplasm Metastasis; Prognosis; Receptor, ErbB-2; Retrospective Studies	2002
A phase II study of cisplatin and vinorelbine in patients with metastatic breast cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13, Issue:11 Topics: Adult; Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bone Neoplasms; Breast Neoplasms; Cisplatin; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Liver Neoplasms; Lung Neoplasms; Megestrol Acetate; Middle Aged; Neoplasm Staging; Probability; Risk Assessment; Soft Tissue Neoplasms; Survival Analysis; Tamoxifen; Vinblastine; Vinorelbine	2002
Postmenopausal women who progress on fulvestrant ('Faslodex') remain sensitive to further endocrine therapy. Breast cancer research and treatment, 2003, Volume: 79, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Androstenedione; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Disease Progression; Double-Blind Method; Down-Regulation; Drug Resistance, Neoplasm; Enzyme Inhibitors; Estradiol; Estrogen Receptor Modulators; Female; Follow-Up Studies; Fulvestrant; Humans; Letrozole; Megestrol Acetate; Middle Aged; Nitriles; Postmenopause; Retrospective Studies; Salvage Therapy; Treatment Outcome; Triazoles	2003
Tamoxifen and megestrol acetate for postmenopausal breast cancer: diverging effects on liver proteins, androgens, and glucocorticoids. Medical oncology (Northwood, London, England), 2004, Volume: 21, Issue:4 Topics: Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Insulin-Like Growth Factor I; Megestrol Acetate; Middle Aged; Postmenopause; Prospective Studies; Sex Hormone-Binding Globulin; Tamoxifen; Testosterone	2004
Endocrine response after prior treatment with fulvestrant in postmenopausal women with advanced breast cancer: experience from a single centre. Endocrine-related cancer, 2006, Volume: 13, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Double-Blind Method; Drug Resistance, Neoplasm; Estradiol; Estrogen Receptor Modulators; Female; Fulvestrant; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Middle Aged; Postmenopause; Prognosis; Retrospective Studies; Salvage Therapy; Survival Rate; Tamoxifen; Treatment Outcome	2006
Elevated plasma tissue inhibitor of metalloproteinase-1 level predicts decreased response and survival in metastatic breast cancer. Cancer, 2007, May-15, Volume: 109, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Breast Neoplasms; Disease Progression; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Fadrozole; Female; Humans; Megestrol Acetate; Middle Aged; Prognosis; Receptor, ErbB-2; Survival Rate; Tissue Inhibitor of Metalloproteinase-1	2007
Adjuvant cyclic Tamoxifen and Megestrol acetate treatment in postmenopausal breast cancer patients--longterm follow-up. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2008, Volume: 34, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Humans; Megestrol Acetate; Middle Aged; Neoplasm Recurrence, Local; Postmenopause; Survival Analysis; Tamoxifen; Time Factors	2008
Phase III randomized placebo-controlled trial of two doses of megestrol acetate as treatment for menopausal symptoms in women with breast cancer: Southwest Oncology Group Study 9626. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Apr-01, Volume: 26, Issue:10 Topics: Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Hot Flashes; Humans; Megestrol Acetate; Menopause; Middle Aged; Placebos; Tamoxifen	2008
Tamoxifen for one year versus two years versus 6 months of Tamoxifen and 6 months of megestrol acetate: a randomized comparison in postmenopausal patients with high-risk breast cancer (DBCG 89C). Acta oncologica (Stockholm, Sweden), 2008, Volume: 47, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Mastectomy, Segmental; Megestrol Acetate; Middle Aged; Postmenopause; Risk Factors; Survival Rate; Tamoxifen; Treatment Outcome	2008
Steroid receptors in megestrol acetate therapy. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1984, Volume: 91 Topics: Antineoplastic Agents; Breast Neoplasms; Clinical Laboratory Techniques; Clinical Trials as Topic; Female; Humans; Megestrol; Megestrol Acetate; Menopause; Palliative Care; Receptors, Androgen; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Progesterone; Receptors, Steroid	1984
Megestrol acetate. Cancer treatment reviews, 1983, Volume: 10, Issue:3 Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Drug Evaluation, Preclinical; Female; Humans; Kidney Neoplasms; Kinetics; Male; Megestrol; Megestrol Acetate; Prostatic Neoplasms; Uterine Neoplasms	1983
Treatment of metastatic breast cancer patients with different dosages of megestrol acetate; dose relations, metabolic and endocrine effects. European journal of cancer & clinical oncology, 1984, Volume: 20, Issue:1 Topics: Administration, Oral; Aged; Blood Glucose; Breast Neoplasms; Cortodoxone; Drug Administration Schedule; Estradiol; Female; Humans; Insulin; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Pituitary Hormones, Anterior; Sex Hormone-Binding Globulin	1984
Elevated serum c-erbB-2 antigen levels and decreased response to hormone therapy of breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antigens; Breast Neoplasms; Chi-Square Distribution; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Fadrozole; Female; Gene Amplification; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Regression Analysis; Survival Analysis; Tamoxifen; Treatment Outcome	1995
Megestrol acetate plus alpha 2a interferon as second line therapy for postmenopausal patients with advanced breast cancer: results of a multicentric phase II trial. Breast cancer research and treatment, 1995, Volume: 33, Issue:3 Topics: Adult; Aged; Breast Neoplasms; Female; Humans; Interferon alpha-2; Interferon-alpha; Megestrol; Megestrol Acetate; Middle Aged; Postmenopause; Recombinant Proteins	1995
Epidermal growth factor receptor expression in breast cancer: association with response to endocrine therapy. Breast cancer research and treatment, 1994, Volume: 29, Issue:1 Topics: Biomarkers, Tumor; Breast Neoplasms; ErbB Receptors; Female; Goserelin; Humans; Ki-67 Antigen; Megestrol; Megestrol Acetate; Menopause; Neoplasm Proteins; Nuclear Proteins; Postmenopause; Premenopause; Prognosis; Proto-Oncogene Proteins; Receptor, ErbB-2; Receptors, Estrogen; Survival Analysis; Tamoxifen	1994
Cyclic sequential endocrine therapy for advanced breast cancer using a combination of tamoxifen and megestrol acetate. Oncology, 1994, Volume: 51 Suppl 1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Survival Rate; Tamoxifen; Treatment Outcome	1994
Megestrol acetate for the prevention of hot flashes. The New England journal of medicine, 1994, Aug-11, Volume: 331, Issue:6 Topics: Breast Neoplasms; Climacteric; Double-Blind Method; Female; Humans; Male; Megestrol; Megestrol Acetate; Middle Aged; Orchiectomy; Prostatic Neoplasms	1994
Adjuvant systemic chemotherapy and hormonal therapy. Effect on local recurrence in the conservatively treated breast cancer patient. Cancer, 1994, May-15, Volume: 73, Issue:10 Topics: Adult; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Humans; Mastectomy, Segmental; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Recurrence, Local; Regression Analysis; Retrospective Studies; Tamoxifen	1994
Effect of megestrol acetate on quality of life in a dose-response trial in women with advanced breast cancer. The Cancer and Leukemia Group B. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1993, Volume: 11, Issue:11 Topics: Appetite; Breast Neoplasms; Dose-Response Relationship, Drug; Female; Humans; Linear Models; Megestrol; Megestrol Acetate; Middle Aged; Multivariate Analysis; Quality of Life; Treatment Outcome; Weight Gain	1993
Randomized comparison of the effects of tamoxifen, megestrol acetate, or tamoxifen plus megestrol acetate on treatment response and survival in patients with metastatic breast cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 1993, Volume: 4, Issue:9 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Receptors, Estrogen; Survival Rate; Tamoxifen	1993
A randomized trial of megestrol acetate with or without premarin in the treatment of potentially responsive metastatic breast cancer. A Study of the Eastern Cooperative Oncology Group (E2185). Cancer, 1996, Feb-01, Volume: 77, Issue:3 Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Disease-Free Survival; Drug Administration Schedule; Drug Therapy, Combination; Estrogens, Conjugated (USP); Female; Humans; Megestrol; Megestrol Acetate; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Survival Rate	1996
Serial serum c-erbB-2 levels in patients with breast carcinoma. Cancer, 1996, Jul-15, Volume: 78, Issue:2 Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Biomarkers, Tumor; Breast Neoplasms; Carcinoma; Disease Progression; Double-Blind Method; Enzyme Inhibitors; Fadrozole; Female; Humans; Megestrol; Megestrol Acetate; Placebos; Prognosis; Receptor, ErbB-2; Remission Induction; Treatment Outcome	1996
Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Volume: 14, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Disease Progression; Double-Blind Method; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Nitriles; Postmenopause; Prognosis; Survival Rate; Tamoxifen; Triazoles	1996
A randomised phase III cross-over study of tamoxifen versus megestrol acetate in advanced and recurrent breast cancer. European journal of cancer (Oxford, England : 1990), 1996, Volume: 32A, Issue:11 Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cross-Over Studies; Female; Humans; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Survival Rate; Tamoxifen; Time Factors; Treatment Failure	1996
A phase III trial comparing anastrozole (1 and 10 milligrams), a potent and selective aromatase inhibitor, with megestrol acetate in postmenopausal women with advanced breast carcinoma. Arimidex Study Group. Cancer, 1997, Feb-15, Volume: 79, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Carcinoma; Double-Blind Method; Enzyme Inhibitors; Female; Humans; Megestrol Acetate; Middle Aged; Nitriles; Postmenopause; Pregnanes; Triazoles	1997
Formestane versus megestrol acetate in postmenopausal breast cancer patients after failure of tamoxifen: a phase III prospective randomised cross over trial of second-line hormonal treatment (SAKK 20/90). Swiss Group for Clinical Cancer Research (SAKK) European journal of cancer (Oxford, England : 1990), 1997, Volume: 33, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Androstenedione; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cross-Over Studies; Female; Humans; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Postmenopause; Prospective Studies; Receptors, Estrogen; Regression Analysis; Remission Induction; Tamoxifen; Time Factors; Treatment Failure	1997
Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:2 Topics: Administration, Oral; Aged; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Disease Progression; Double-Blind Method; Enzyme Inhibitors; Female; Humans; Letrozole; Megestrol Acetate; Middle Aged; Nitriles; Survival Rate; Triazoles	1998
Long term use of megestrol acetate by cancer survivors for the treatment of hot flashes. Cancer, 1998, May-01, Volume: 82, Issue:9 Topics: Breast Neoplasms; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hot Flashes; Humans; Male; Megestrol Acetate; Prostatic Neoplasms	1998
Profound suppression of plasma estrogens by megestrol acetate in postmenopausal breast cancer patients. Clinical cancer research : an official journal of the American Association for Cancer Research, 1996, Volume: 2, Issue:9 Topics: Administration, Oral; Aged; Androstenedione; Appetite Stimulants; Area Under Curve; Breast Neoplasms; Dehydroepiandrosterone Sulfate; Dose-Response Relationship, Drug; Estrogens; Estrone; Female; Follicle Stimulating Hormone; Humans; Hydrocortisone; Luteinizing Hormone; Megestrol Acetate; Middle Aged; Postmenopause; Testosterone	1996
Changes in cytokine production of breast cancer patients treated with interferons. Cytokine, 1998, Volume: 10, Issue:12 Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Combined Modality Therapy; Cytokines; Female; Humans; Interferon-beta; Interferon-gamma; Interleukin-1; Megestrol Acetate; Prognosis; Receptors, Estrogen; Receptors, Interleukin-2; Recombinant Proteins; Tamoxifen	1998
First-line treatment with mitoxantrone, methotrexate, vincristine, and carboplatine (MIMOC) plus cyclical hormonotherapy with tamoxifen and megestrol acetate in advanced breast cancer. American journal of clinical oncology, 1999, Volume: 22, Issue:3 Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Estrogen Antagonists; Female; Humans; Megestrol Acetate; Methotrexate; Middle Aged; Mitoxantrone; Neoplasm Metastasis; Neoplasm Staging; Receptors, Estrogen; Survival Analysis; Tamoxifen; Vincristine	1999
Randomized phase III trial comparing the new potent and selective third-generation aromatase inhibitor vorozole with megestrol acetate in postmenopausal advanced breast cancer patients. North American Vorozole Study Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999, Volume: 17, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Disease Progression; Enzyme Inhibitors; Female; Humans; Megestrol Acetate; Middle Aged; Postmenopause; Triazoles	1999
Dose-response trial of megestrol acetate in advanced breast cancer: cancer and leukemia group B phase III study 8741. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999, Volume: 17, Issue:1 Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Disease Progression; Dose-Response Relationship, Drug; Female; Humans; Megestrol Acetate; Middle Aged; Prospective Studies; Survival Rate	1999
Quality of life in postmenopausal patients with breast cancer after failure of tamoxifen: formestane versus megestrol acetate as second-line hormonal treatment. Swiss Group for Clinical Cancer Research (SAKK). European journal of cancer (Oxford, England : 1990), 1999, Volume: 35, Issue:6 Topics: Adaptation, Psychological; Adult; Aged; Aged, 80 and over; Androstenedione; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Megestrol Acetate; Middle Aged; Quality of Life; Tamoxifen; Treatment Failure	1999
Defining clinical benefit in postmenopausal patients with breast cancer under second-line endocrine treatment: does quality of life matter? Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999, Volume: 17, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Androstenedione; Antineoplastic Agents; Breast Neoplasms; Disease-Free Survival; Female; Health Status; Humans; Megestrol Acetate; Middle Aged; Postmenopause; Quality of Life; Statistics as Topic; Treatment Outcome	1999
Static disease on anastrozole provides similar benefit as objective response in patients with advanced breast cancer. Breast cancer research and treatment, 1999, Volume: 58, Issue:2 Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme Inhibitors; Europe; Female; Humans; Megestrol Acetate; Nitriles; Postmenopause; Prospective Studies; Survival Analysis; Triazoles; United States	1999
Exemestane is superior to megestrol acetate after tamoxifen failure in postmenopausal women with advanced breast cancer: results of a phase III randomized double-blind trial. The Exemestane Study Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:7 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Androstadienes; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Breast Neoplasms; Disease Progression; Double-Blind Method; Female; Humans; Megestrol Acetate; Middle Aged; Neoplasm Recurrence, Local; Pain; Postmenopause; Quality of Life; Survival Analysis; Tamoxifen; Treatment Outcome	2000
Exemestane improves survival compared with megoestrol acetate in postmenopausal patients with advanced breast cancer who have failed on tamoxifen. results Of a double-blind randomised phase III trial. European journal of cancer (Oxford, England : 1990), 2000, Volume: 36 Suppl 4 Topics: Androstadienes; Antineoplastic Agents; Breast Neoplasms; Double-Blind Method; Enzyme Inhibitors; Female; Humans; Megestrol Acetate; Postmenopause; Survival Analysis; Tamoxifen; Treatment Failure	2000
Phase III, multicenter, double-blind, randomized study of letrozole, an aromatase inhibitor, for advanced breast cancer versus megestrol acetate. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Jul-15, Volume: 19, Issue:14 Topics: Aged; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Double-Blind Method; Enzyme Inhibitors; Female; Humans; Letrozole; Megestrol Acetate; Middle Aged; Nitriles; Postmenopause; Proportional Hazards Models; Receptors, Estrogen; Receptors, Progesterone; Triazoles	2001
Exemestane improves survival in metastatic breast cancer: results of a phase III randomized study. Clinical breast cancer, 2000, Volume: 1 Suppl 1 Topics: Administration, Oral; Aged; Androstadienes; Aromatase Inhibitors; Breast Neoplasms; Double-Blind Method; Female; Humans; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Postmenopause; Survival Analysis; Treatment Outcome	2000
Potential applications of high-dose megestrol acetate in breast cancer. Oncology, 1992, Volume: 49 Suppl 2 Topics: Adult; Aged; Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged	1992
High-dose megestrol acetate as third-line endocrine therapy for metastatic breast cancer. Oncology, 1992, Volume: 49 Suppl 2 Topics: Adult; Aged; Aged, 80 and over; Body Weight; Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis	1992
A randomised trial of second-line hormone vs single agent chemotherapy in tamoxifen resistant advanced breast cancer. British journal of cancer, 1992, Volume: 66, Issue:2 Topics: Breast Neoplasms; Drug Resistance; Female; Humans; Megestrol; Megestrol Acetate; Mitoxantrone; Neoplasm Staging; Probability; Prospective Studies; Receptors, Estrogen; Tamoxifen; Time Factors; Treatment Outcome	1992
Megestrol acetate: phase II study of a single daily administration in advanced breast cancer. Breast cancer research and treatment, 1990, Volume: 17, Issue:1 Topics: Body Weight; Breast Neoplasms; Combined Modality Therapy; Drug Administration Schedule; Drug Evaluation; Female; Humans; Megestrol; Megestrol Acetate; Menopause	1990
A randomized comparison of megestrol acetate (MA) and medroxyprogesterone acetate (MPA) in patients with advanced breast cancer. European journal of cancer (Oxford, England : 1990), 1990, Volume: 26, Issue:3 Topics: Aged; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged; Randomized Controlled Trials as Topic	1990
Adrenal steroids as parameters of the bioavailability of MA and MPA. European journal of cancer (Oxford, England : 1990), 1990, Volume: 26, Issue:3 Topics: Adrenal Cortex Hormones; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Biological Availability; Breast Neoplasms; Dehydroepiandrosterone; Estradiol; Estrone; Female; Humans; Hydrocortisone; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate	1990
Influence of progestins on serum hormone levels in postmenopausal women with advanced breast cancer--II. A differential effect of megestrol acetate and medroxyprogesterone acetate on serum estrone sulfate and sex hormone binding globulin. Journal of steroid biochemistry, 1990, Volume: 36, Issue:1-2 Topics: Aged; Aged, 80 and over; Breast Neoplasms; Estradiol; Estrone; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged; Sex Hormone-Binding Globulin	1990
High- versus standard-dose megestrol acetate in women with advanced breast cancer: a phase III trial of the Piedmont Oncology Association. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1990, Volume: 8, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Cardiovascular Diseases; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Survival Rate; Weight Gain	1990
Front-line hormonal therapy for patients with advanced breast cancer: a community oncology research program. Seminars in oncology, 1990, Volume: 17, Issue:6 Suppl 9 Topics: Breast Neoplasms; Humans; Megestrol; Megestrol Acetate	1990
Comparison of antiestrogen and progestogen therapy for initial treatment and consequences of their combination for second-line treatment of recurrent breast cancer. Seminars in oncology, 1990, Volume: 17, Issue:6 Suppl 9 Topics: Breast Neoplasms; Drug Therapy, Combination; Female; Humans; Megestrol; Megestrol Acetate; Tamoxifen	1990
Weight changes in women with metastatic breast cancer treated with megestrol acetate: a comparison of standard versus high-dose therapy. Seminars in oncology, 1990, Volume: 17, Issue:6 Suppl 9 Topics: Blood Pressure; Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Neoplasm Metastasis; Weight Gain	1990
[Megestrol acetate versus medroxyprogesterone acetate in the treatment of metastasizing breast cancers. Intermediate report of a multicenter phase III study]. Onkologie, 1987, Volume: 10, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Female; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Random Allocation	1987
[Megestrol acetate in various doses in the treatment of metastatic breast carcinoma--clinical and endocrinologic studies]. Klinische Wochenschrift, 1985, Apr-01, Volume: 63, Issue:7 Topics: Adrenocorticotropic Hormone; Adult; Aged; Aldosterone; Breast Neoplasms; Female; Humans; Hydrocortisone; Male; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Neoplasm Metastasis; Prolactin; Receptors, Cell Surface; Testosterone	1985
Megestrol acetate v tamoxifen in advanced breast cancer: correlation of hormone receptors and response. Seminars in oncology, 1986, Volume: 13, Issue:4 Suppl 4 Topics: Antineoplastic Agents; Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasms, Hormone-Dependent; Random Allocation; Receptors, Cell Surface; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen	1986
Megestrol acetate versus tamoxifen in advanced breast cancer: 5-year analysis--a phase III trial of the Piedmont Oncology Association. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1988, Volume: 6, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Random Allocation; Remission Induction; Tamoxifen	1988
Megestrol acetate: a new role in the treatment of metastatic breast cancer. Seminars in hematology, 1987, Volume: 24, Issue:2 Suppl 1 Topics: Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Neoplasm Metastasis; Tamoxifen	1987
Megestrol acetate v tamoxifen in advanced breast cancer: a phase III trial of the Piedmont Oncology Association (POA). Seminars in oncology, 1985, Volume: 12, Issue:1 Suppl 1 Topics: Aged; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Tamoxifen	1985
Metastatic breast cancer: preliminary results with oral hormonal therapy. Seminars in oncology, 1985, Volume: 12, Issue:4 Suppl 6 Topics: Administration, Oral; Adult; Aged; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Random Allocation; Tamoxifen	1985
LHRH-agonist treatment in clinical and experimental human breast cancer. Journal of steroid biochemistry, 1985, Volume: 23, Issue:5B Topics: Administration, Intranasal; Breast Neoplasms; Buserelin; Cell Line; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Megestrol; Megestrol Acetate; Menopause; Menstrual Cycle; Progesterone; Prolactin; Receptors, Estradiol; Tamoxifen	1985

Other Studies

87 other study(ies) available for megestrol acetate and Breast Cancer

Article	Year
Reversal of the human and murine multidrug-resistance phenotype with megestrol acetate. Cancer chemotherapy and pharmacology, 1994, Volume: 34, Issue:2 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Colonic Neoplasms; Dactinomycin; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Female; Flow Cytometry; Humans; Mammary Neoplasms, Experimental; Megestrol; Megestrol Acetate; Mice; Mice, Nude; Neoplasm Transplantation; Phenotype; Transplantation, Heterologous; Tumor Cells, Cultured	1994
Progestin as an alternative treatment option for multi-treated recurrent triple-negative breast cancer. Swiss medical weekly, 2013, Volume: 143 Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Medroxyprogesterone Acetate; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Retrospective Studies; Salvage Therapy; Treatment Outcome	2013
Megestrol acetate may stimulate the production of insulin-like growth factor 1 in breast tissues of women with breast cancer. Hormone molecular biology and clinical investigation, 2013, Volume: 13, Issue:3 Topics: Aged; Antineoplastic Agents, Hormonal; Breast; Breast Neoplasms; Female; Humans; Insulin-Like Growth Factor I; Megestrol Acetate; Middle Aged; Receptors, Estrogen; Receptors, Progesterone; Sex Hormone-Binding Globulin; Tamoxifen	2013
Multi Drug Loaded Thermo-Responsive Fibrinogen-graft-Poly(N-vinyl Caprolactam) Nanogels for Breast Cancer Drug Delivery. Journal of biomedical nanotechnology, 2015, Volume: 11, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Caprolactam; Cell Line, Tumor; Cell Survival; Delayed-Action Preparations; Diffusion; Fibrinogen; Fluorouracil; Humans; Hydrogels; Megestrol Acetate; Nanocapsules; Particle Size; Polymers; Receptors, Vitronectin; Temperature	2015
Risk of type 2 diabetes mellitus in female breast cancer patients treated with morphine: A retrospective population-based time-dependent cohort study. Diabetes research and clinical practice, 2015, Volume: 110, Issue:3 Topics: Adult; Aged; Aromatase Inhibitors; Breast Neoplasms; Diabetes Mellitus, Type 2; Female; Humans; Incidence; Megestrol Acetate; Middle Aged; Morphine; Proportional Hazards Models; Retrospective Studies; Risk Factors; Taiwan; Tamoxifen; Young Adult	2015
Time to revisit 'Megace' for hot flushes in patients with breast cancer? BMJ supportive & palliative care, 2018, Volume: 8, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Guidelines as Topic; Hormone Replacement Therapy; Hot Flashes; Humans; Megestrol Acetate; Middle Aged	2018
Temporal trends in the use of adjuvant systemic therapy in breast cancer: a population based study in Sweden 1976-2005. Acta oncologica (Stockholm, Sweden), 2009, Volume: 48, Issue:1 Topics: Adult; Age Factors; Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Goserelin; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Middle Aged; Ovariectomy; Sweden; Tamoxifen	2009
The Functional Living Index-Cancer: estimating its reliability based on clinical trial data. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 2010, Volume: 19, Issue:1 Topics: Aged; Antineoplastic Agents; Belgium; Breast Neoplasms; Discriminant Analysis; Female; Humans; Longitudinal Studies; Megestrol Acetate; Middle Aged; Patient Participation; Psychometrics; Quality of Life; Reproducibility of Results; Surveys and Questionnaires; Triazoles	2010
Sensitivity to further endocrine therapy is retained following progression on first-line fulvestrant. Breast cancer research and treatment, 2005, Volume: 92, Issue:2 Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Drug Resistance, Neoplasm; Estradiol; Female; Fulvestrant; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Postmenopause; Retrospective Studies; Salvage Therapy; Tamoxifen; Treatment Outcome	2005
Clinically occult cutaneous metastases. Journal of the American Academy of Dermatology, 2006, Volume: 55, Issue:6 Topics: Aged; Aged, 80 and over; Anastrozole; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast Neoplasms; Capecitabine; Carcinoma; Carcinoma, Basal Cell; Carcinoma, Lobular; Carcinoma, Signet Ring Cell; Deoxycytidine; Estradiol; Facial Neoplasms; Female; Fluorouracil; Fulvestrant; Humans; Incidental Findings; Letrozole; Mastectomy, Radical; Megestrol Acetate; Melanoma; Neoplasms, Second Primary; Neoplastic Cells, Circulating; Nitriles; Selective Estrogen Receptor Modulators; Skin Neoplasms; Tamoxifen; Triazoles; Wound Healing	2006
Megestrol acetate-induced adrenal insufficiency. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2008, Volume: 10, Issue:4 Topics: Adrenal Insufficiency; Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Humans; Megestrol Acetate; Pericardial Effusion	2008
Treatment of advanced breast cancer with megestrol acetate after therapy with tamoxifen. Cancer, 1982, Feb-01, Volume: 49, Issue:3 Topics: Adult; Aged; Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Palliative Care; Prognosis; Tamoxifen	1982
The role of progestins in the treatment of breast cancer. Seminars in oncology, 1983, Volume: 10, Issue:4 Suppl 4 Topics: Breast Neoplasms; Cell Line; Cytoplasm; Dose-Response Relationship, Drug; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen	1983
Endocrine effects of the combination of megestrol acetate and tamoxifen in the treatment of metastatic breast cancer. European journal of cancer & clinical oncology, 1984, Volume: 20, Issue:9 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Estradiol; Female; Follicle Stimulating Hormone; Humans; Hydrocortisone; Luteinizing Hormone; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Neoplasm Metastasis; Prolactin; Sex Hormone-Binding Globulin; Tamoxifen; Thyrotropin-Releasing Hormone	1984
Long-term LHRH-agonist treatment in metastatic breast cancer as a single treatment and in combination with other additive endocrine treatments. Medical oncology and tumor pharmacotherapy, 1984, Volume: 1, Issue:2 Topics: Breast Neoplasms; Buserelin; Drug Therapy, Combination; Female; Humans; Megestrol; Megestrol Acetate; Tamoxifen	1984
Megestrol acetate flare. Cancer treatment reports, 1983, Volume: 67, Issue:4 Topics: Bone Neoplasms; Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Pain	1983
Clinical results with megestrol acetate in patients with advanced carcinoma of the breast. Surgery, gynecology & obstetrics, 1982, Volume: 155, Issue:6 Topics: Antineoplastic Agents; Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged	1982
Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy. British journal of cancer, 1995, Volume: 72, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Breast Neoplasms; ErbB Receptors; Estrogen Antagonists; Female; Gene Expression Regulation, Neoplastic; Goserelin; Humans; Ki-67 Antigen; Life Tables; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Nuclear Proteins; Proportional Hazards Models; Proto-Oncogene Proteins p21(ras); Receptor, ErbB-2; Receptors, Estrogen; Tamoxifen; Treatment Outcome; Tumor Suppressor Protein p53	1995
Response of brain metastases from breast cancer to megestrol acetate: a case report. Journal of neuro-oncology, 1995, Volume: 24, Issue:3 Topics: Adenocarcinoma; Antineoplastic Agents; Breast Neoplasms; Cerebellar Neoplasms; Combined Modality Therapy; Disease Progression; Fatal Outcome; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Recurrence, Local	1995
Changes in serum sex steroid levels during megestrol acetate therapy. Surgical oncology, 1994, Volume: 3, Issue:6 Topics: Adrenalectomy; Aged; Antibodies; Breast Neoplasms; Cross Reactions; Dehydroepiandrosterone; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Hormones; Humans; Luteinizing Hormone; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Staging; Ovariectomy; Postmenopause; Prospective Studies; Radioimmunoassay	1994
Fibroid growth in response to high-dose progestogen. Fertility and sterility, 1995, Volume: 64, Issue:1 Topics: Breast Neoplasms; Carcinoma; Dose-Response Relationship, Drug; Female; Humans; Leiomyoma; Megestrol; Megestrol Acetate; Middle Aged; Progestins; Tamoxifen; Ultrasonography; Uterine Neoplasms	1995
Transvaginal sonography in a woman treated with megestrol acetate for breast cancer. Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine, 1994, Volume: 13, Issue:8 Topics: Atrophy; Breast Neoplasms; Dilatation and Curettage; Endometrium; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Postmenopause; Ultrasonography; Uterine Hemorrhage	1994
Estrogen and progesterone receptor expression of decidual endometrium in a postmenopausal woman treated with tamoxifen and megestrol acetate. Gynecologic and obstetric investigation, 1994, Volume: 38, Issue:2 Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Endometrium; Estrogens; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Postmenopause; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen	1994
Megestrol acetate in advanced breast carcinoma. Oncology, 1994, Volume: 51 Suppl 1 Topics: Aminoglutethimide; Breast Neoplasms; Carcinoma; Clinical Trials as Topic; Cross-Over Studies; Female; Humans; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Postmenopause; Prospective Studies; Randomized Controlled Trials as Topic; Tamoxifen; Treatment Outcome	1994
Aromatase inhibitors in metastatic breast cancer. Seminars in oncology, 1996, Volume: 23, Issue:4 Suppl 9 Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Fadrozole; Female; Humans; Megestrol Acetate; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Nitriles; Tamoxifen; Triazoles	1996
Sensitization to doxorubicin resistance in breast cancer cell lines by tamoxifen and megestrol acetate. Biochemical pharmacology, 1996, Oct-11, Volume: 52, Issue:7 Topics: Breast Neoplasms; Doxorubicin; Drug Resistance, Neoplasm; Female; Humans; Megestrol Acetate; Tamoxifen; Tumor Cells, Cultured	1996
Effects of treatment with megestrol acetate, aminoglutethimide, or formestane on insulin-like growth factor (IGF) I and II, IGF-binding proteins (IGFBPs), and IGFBP-3 protease status in patients with advanced breast cancer. The Journal of clinical endocrinology and metabolism, 1996, Volume: 81, Issue:6 Topics: Aged; Aged, 80 and over; Aminoglutethimide; Androstenedione; Aromatase Inhibitors; Blotting, Western; Breast Neoplasms; Endopeptidases; Female; Humans; Insulin-Like Growth Factor Binding Proteins; Megestrol Acetate; Middle Aged; Radioimmunoassay; Somatomedins	1996
Excessive sweating: unusual side effect of megestrol acetate therapy. Tennessee medicine : journal of the Tennessee Medical Association, 1997, Volume: 90, Issue:2 Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Humans; Megestrol Acetate; Middle Aged; Sweating	1997
Clinical adrenal insufficiency in patients receiving megestrol therapy. Archives of internal medicine, 1997, May-12, Volume: 157, Issue:9 Topics: Administration, Oral; Adrenal Glands; Anorexia; Antineoplastic Agents, Hormonal; Breast Neoplasms; Diarrhea; Fatigue; Female; Humans; Hydrocortisone; Hypotension; Megestrol Acetate; Middle Aged; Nausea; Treatment Outcome; Vomiting	1997
Aromatase inhibitors for breast cancer--further progress. European journal of cancer (Oxford, England : 1990), 1997, Volume: 33, Issue:7 Topics: Aminoglutethimide; Androstenedione; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Megestrol Acetate	1997
Predictors of response to second-line endocrine therapy for breast cancer. Breast cancer research and treatment, 1997, Volume: 45, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Aminoglutethimide; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Gonanes; Goserelin; Humans; Megestrol Acetate; Middle Aged; Nitriles; Ovariectomy; Predictive Value of Tests; Remission Induction; Tamoxifen; Triazoles	1997
A rare event of megestrol acetate (Megace)-induced adrenal suppression in a breast cancer patient. American journal of clinical oncology, 1997, Volume: 20, Issue:6 Topics: Adrenal Glands; Adrenal Insufficiency; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Therapy, Combination; Female; Humans; Megestrol Acetate; Neoplasms, Hormone-Dependent	1997
Progestin regulation of vascular endothelial growth factor in human breast cancer cells. Cancer research, 1998, Feb-01, Volume: 58, Issue:3 Topics: Breast Neoplasms; Endometrial Neoplasms; Endothelial Growth Factors; Female; Gene Expression Regulation, Neoplastic; Humans; Lymphokines; Medroxyprogesterone Acetate; Megestrol Acetate; Mifepristone; Neoplasm Proteins; Neovascularization, Pathologic; Norethindrone; Norethynodrel; Norgestrel; Progesterone; Progestins; Receptors, Progesterone; Stimulation, Chemical; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	1998
Differential regulation of the human 'leukemia inhibitory factor' (LIF) promoter in T47D and MDA-MB 231 breast cancer cells. Breast cancer research and treatment, 1998, Volume: 47, Issue:2 Topics: Breast Neoplasms; Estradiol; Female; Gene Expression Regulation, Neoplastic; Growth Inhibitors; Humans; Interleukin-6; Leukemia Inhibitory Factor; Lymphokines; Megestrol Acetate; Pregnadienes; Progesterone Congeners; Promoter Regions, Genetic; Transfection; Tumor Cells, Cultured	1998
Induction of prostate-specific antigen expression by synthetic progestins in patients with prostate and breast cancer. Mayo Clinic proceedings, 1998, Volume: 73, Issue:7 Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Megestrol Acetate; Progesterone Congeners; Prostate-Specific Antigen; Prostatic Neoplasms; Tumor Cells, Cultured; Up-Regulation	1998
Prognostic value of plasma prostate specific antigen after megestrol acetate treatment in patients with metastatic breast carcinoma. Cancer, 1999, Feb-15, Volume: 85, Issue:4 Topics: Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Dose-Response Relationship, Drug; Female; Humans; Megestrol Acetate; Middle Aged; Multivariate Analysis; Progestins; Prognosis; Proportional Hazards Models; Prostate-Specific Antigen; Survival Analysis; Tamoxifen	1999
Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT-B. Breast cancer research and treatment, 1999, Volume: 55, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Evaluation Studies as Topic; Female; Hormone Replacement Therapy; Humans; Megestrol Acetate; Menopause; Middle Aged; Nitriles; Pilot Projects; Quality of Life; Surveys and Questionnaires; Tamoxifen; Time Factors; Triazoles	1999
Megestrol acetate therapy and secondary adrenal suppression. Cancer, 1999, Sep-15, Volume: 86, Issue:6 Topics: Adrenal Glands; Adrenocorticotropic Hormone; Aged; Antineoplastic Agents; Breast Neoplasms; Corticotropin-Releasing Hormone; Cosyntropin; Female; Humans; Hydrocortisone; Hypoaldosteronism; Hypothalamo-Hypophyseal System; Megestrol Acetate; Middle Aged; Ovarian Neoplasms; Pituitary-Adrenal System	1999
Effects of treatment with megestrol acetate on the insulin-like growth factor system: time and dose dependency. European journal of cancer (Oxford, England : 1990), 1999, Volume: 35, Issue:7 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Blotting, Western; Breast Neoplasms; Dose-Response Relationship, Drug; Female; Humans; Insulin-Like Growth Factor Binding Proteins; Insulin-Like Growth Factor I; Megestrol Acetate; Middle Aged; Postmenopause	1999
Letrozole: updated duration of response. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999, Volume: 17, Issue:12 Topics: Antineoplastic Agents; Breast Neoplasms; Female; Humans; Letrozole; Megestrol Acetate; Nitriles; Postmenopause; Survival Analysis; Triazoles	1999
Safety and tolerability of endocrine therapies used in the treatment of advanced breast cancer. Annals of surgical oncology, 1999, Volume: 6, Issue:8 Suppl Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Drug Tolerance; Female; Humans; Megestrol Acetate; Nitriles; Safety; Tamoxifen; Triazoles	1999
Future directions in endocrine treatment of advanced breast cancer. Annals of surgical oncology, 1999, Volume: 6, Issue:8 Suppl Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Megestrol Acetate; Nitriles; Tamoxifen; Triazoles	1999
Cost-utility analysis of second-line hormonal therapy in advanced breast cancer: a comparison of two aromatase inhibitors to megestrol acetate. Anti-cancer drugs, 2000, Volume: 11, Issue:7 Topics: Anastrozole; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Canada; Costs and Cost Analysis; Decision Support Techniques; Female; Humans; Letrozole; Megestrol Acetate; Nitriles; Quality of Life; Randomized Controlled Trials as Topic; Triazoles	2000
Clarification of anastrozole/megestrol acetate trial program design. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Dec-15, Volume: 18, Issue:24 Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Clinical Trials, Phase III as Topic; Enzyme Inhibitors; Female; Humans; Megestrol Acetate; Nitriles; Prospective Studies; Research Design; Triazoles	2000
Hemostatic effects of high-dose megestrol acetate therapy in patients with advanced gynecological cancer. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2001, Volume: 15, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Blood Coagulation; Breast Neoplasms; Endometrial Neoplasms; Female; Fibrinolysis; Genital Neoplasms, Female; Humans; Megestrol Acetate; Middle Aged; Ovarian Neoplasms; Thrombosis	2001
Letrozole in second-line therapy of advanced breast cancer: more questions than answers. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Dec-01, Volume: 19, Issue:23 Topics: Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Canada; Clinical Trials, Phase III as Topic; Drug Administration Schedule; Europe; Female; Humans; Letrozole; Megestrol Acetate; Neoplasm Metastasis; Nitriles; Palliative Care; Postmenopause; Treatment Outcome; Triazoles	2001
Combining components of quality of life to increase precision and evaluate trade-offs. Statistics in medicine, 2001, Nov-15, Volume: 20, Issue:21 Topics: Antineoplastic Combined Chemotherapy Protocols; Bias; Biometry; Breast Neoplasms; Clinical Trials as Topic; Data Interpretation, Statistical; Female; Humans; Linear Models; Megestrol Acetate; Multivariate Analysis; Quality of Life	2001
Estrogen as therapy for breast cancer. Breast cancer research : BCR, 2002, Volume: 4, Issue:4 Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Breast Neoplasms; Clinical Trials, Phase II as Topic; Diethylstilbestrol; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Estrogens; Female; Humans; Letrozole; Megestrol Acetate; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Salvage Therapy; Tamoxifen; Treatment Outcome; Triazoles	2002
Comparison of two oestrogen receptor assays in the prediction of the clinical course of patients with advanced breast cancer. British journal of cancer, 1992, Volume: 65, Issue:5 Topics: Aged; Aging; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Immunoenzyme Techniques; Immunohistochemistry; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Predictive Value of Tests; Prognosis; Receptors, Estrogen; Sensitivity and Specificity; Tamoxifen	1992
Longterm remission of multiple brain metastases with tamoxifen. Journal of neuro-oncology, 1991, Volume: 10, Issue:2 Topics: Activities of Daily Living; Aged; Antineoplastic Agents; Brain Neoplasms; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Combined Modality Therapy; Estrogens; Female; Humans; Mastectomy, Radical; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Palliative Care; Psychomotor Disorders; Tamoxifen	1991
A pilot study of stanozolol for advanced breast carcinoma. Cancer, 1991, Jun-15, Volume: 67, Issue:12 Topics: Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Carcinoma; Female; Humans; Lymphatic Metastasis; Megestrol; Megestrol Acetate; Middle Aged; Pilot Projects; Remission Induction; Stanozolol; Tamoxifen	1991
The relationship of chemotherapeutic and endocrine intervention on natural killer cell activity in human breast cancer. Cancer, 1991, Aug-01, Volume: 68, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cytotoxicity, Immunologic; Humans; Immunity, Innate; Killer Cells, Natural; Leukocyte Count; Male; Megestrol; Megestrol Acetate; Neoplasm Metastasis; Neoplasm Staging; Tamoxifen	1991
An objective biochemical assessment of therapeutic response in metastatic breast cancer: a study with external review of clinical data. British journal of cancer, 1990, Volume: 61, Issue:1 Topics: Biomarkers, Tumor; Blood Sedimentation; Bone Neoplasms; Breast Neoplasms; Buserelin; C-Reactive Protein; Carcinoembryonic Antigen; Female; Ferritins; Goserelin; Humans; Lung Neoplasms; Megestrol; Megestrol Acetate; Orosomucoid; Ovariectomy; Tamoxifen	1990
Serum ferritin as a marker of therapeutic response in stage III and IV breast cancer. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 1990, Volume: 16, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Bone Neoplasms; Breast Neoplasms; Buserelin; Female; Ferritins; Follow-Up Studies; Goserelin; Humans; Lung Neoplasms; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Staging; Ovariectomy; Remission Induction; Retrospective Studies; Tamoxifen	1990
Treatment of cancer anorexia with megestrol acetate: impact on quality of life. Oncology (Williston Park, N.Y.), 1990, Volume: 4, Issue:5 Topics: Anorexia; Appetite; Breast Neoplasms; Eating; Feeding and Eating Disorders; Female; Humans; Megestrol; Megestrol Acetate; Placebos; Psychological Tests; Quality of Life; Weight Loss	1990
Determination of megestrol acetate and cyproterone acetate in serum of patients with advanced breast cancer by high-performance liquid chromatography. Journal of chromatography, 1990, Jul-13, Volume: 529, Issue:1 Topics: Antineoplastic Agents; Breast Neoplasms; Chromatography, High Pressure Liquid; Cyproterone; Cyproterone Acetate; Gas Chromatography-Mass Spectrometry; Humans; Megestrol; Megestrol Acetate	1990
Complete remission of a brain metastasis to third-line hormonal treatment with megestrol acetate. American journal of clinical oncology, 1990, Volume: 13, Issue:6 Topics: Brain Neoplasms; Breast Neoplasms; Carbamazepine; Carcinoma, Intraductal, Noninfiltrating; Dexamethasone; Female; Humans; Lymphatic Metastasis; Megestrol; Megestrol Acetate; Middle Aged; Ovariectomy; Remission Induction	1990
Influence of aminoglutethimide on the metabolism of medroxyprogesterone acetate and megestrol acetate in postmenopausal patients with advanced breast cancer. Cancer chemotherapy and pharmacology, 1990, Volume: 27, Issue:2 Topics: Administration, Oral; Aged; Aminoglutethimide; Breast Neoplasms; Drug Interactions; Female; Humans; Injections, Intravenous; Medroxyprogesterone; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Progestins	1990
Influence of progestins on serum hormone levels in postmenopausal women with advanced breast cancer--I. General findings. Journal of steroid biochemistry, 1990, Volume: 36, Issue:1-2 Topics: Aged; Androgens; Breast Neoplasms; Estrogens; Estrone; Female; Hormones; Humans; Medroxyprogesterone; Megestrol; Megestrol Acetate; Middle Aged; Sex Hormone-Binding Globulin; Transcortin	1990
Oral high-dose progestins as treatment for advanced breast cancer. Acta oncologica (Stockholm, Sweden), 1989, Volume: 28, Issue:6 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Drug Administration Schedule; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged; Receptors, Estrogen; Receptors, Progesterone; Remission Induction; Retrospective Studies	1989
Factors predicting the response of patients with advanced breast cancer to endocrine (Megace) therapy. European journal of cancer & clinical oncology, 1989, Volume: 25, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen	1989
Jaundice and intrahepatic cholestasis following high-dose megestrol acetate for breast cancer. Cancer, 1989, Feb-01, Volume: 63, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bilirubin; Breast Neoplasms; Cholestasis, Intrahepatic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Jaundice; Mastectomy, Radical; Megestrol; Megestrol Acetate; Methotrexate; Prednisone; Vincristine	1989
Phase II evaluation of megestrol acetate in previously treated patients with advanced breast cancer: relationship of response to previous treatment. European journal of cancer & clinical oncology, 1986, Volume: 22, Issue:9 Topics: Adult; Aged; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Drug Evaluation; Female; Hormones; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged	1986
Effect of oral high-dose progestins on the disposition of antipyrine, digitoxin, and warfarin in patients with advanced breast cancer. Cancer chemotherapy and pharmacology, 1986, Volume: 18, Issue:3 Topics: Administration, Oral; Aged; Aged, 80 and over; Antipyrine; Breast Neoplasms; Digitoxin; Female; Humans; Kinetics; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged; Progesterone Congeners; Warfarin	1986
Plasma concentrations of medroxyprogesterone acetate and megesterol acetate during long-term follow-up in patients treated for metastatic breast cancer. Journal of cancer research and clinical oncology, 1988, Volume: 114, Issue:2 Topics: Aged; Breast Neoplasms; Female; Follow-Up Studies; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Radioimmunoassay	1988
[Which hormone therapy should be used in advanced breast carcinoma in males?]. Deutsche medizinische Wochenschrift (1946), 1988, Sep-02, Volume: 113, Issue:35 Topics: Adenocarcinoma; Aged; Aminoglutethimide; Axilla; Breast Neoplasms; Dexamethasone; Drug Evaluation; Humans; Lymphatic Metastasis; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Tamoxifen; Testolactone; Testosterone Congeners	1988
Progestational agents in advanced breast cancer: an overview. Seminars in oncology, 1986, Volume: 13, Issue:4 Suppl 4 Topics: Antineoplastic Agents; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Menopause; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Hormone-Dependent; Prognosis; Receptors, Cell Surface; Tamoxifen	1986
The use of serum carcinoembryonic antigen to assess therapeutic response in locally advanced and metastatic breast cancer: a prospective study with external review. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 1988, Volume: 14, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Carcinoembryonic Antigen; Female; Humans; Lung Neoplasms; Megestrol; Megestrol Acetate; Middle Aged; Prospective Studies; Tamoxifen; Viscera	1988
Quantitative estrogen and progesterone receptor levels related to progression-free interval in advanced breast cancer patients treated with megestrol acetate or tamoxifen. Seminars in oncology, 1988, Volume: 15, Issue:2 Suppl 1 Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Regression Analysis; Retrospective Studies; Tamoxifen	1988
Megestrol acetate as primary hormonal therapy for advanced breast cancer. Seminars in oncology, 1988, Volume: 15, Issue:2 Suppl 1 Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies	1988
Sequential hormone therapy for advanced breast cancer. Seminars in oncology, 1988, Volume: 15, Issue:2 Suppl 1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Soft Tissue Neoplasms; Tamoxifen	1988
High-dose megestrol acetate in the treatment of advanced breast cancer. Seminars in oncology, 1988, Volume: 15, Issue:2 Suppl 1 Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Humans; Male; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Neoplasm Metastasis	1988
Investigations on the nutritional status of advanced breast cancer patients. The influence of long-term treatment with megestrol acetate or tamoxifen. Nutrition and cancer, 1987, Volume: 10, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Catecholamines; Female; Humans; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Nutritional Status; Pyridoxine; Steroids; Tamoxifen; Trace Elements	1987
Combination hormone therapy for metastatic breast cancer. An ECOG study of megestrol and aminoglutethimide. Cancer, 1987, Nov-01, Volume: 60, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Hydrocortisone; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local	1987
High-dose megestrol acetate for the treatment of advanced breast cancer: dose and toxicities. Seminars in hematology, 1987, Volume: 24, Issue:2 Suppl 1 Topics: Aged; Appetite; Body Weight; Breast Neoplasms; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Male; Megestrol; Megestrol Acetate; Menopause; Middle Aged	1987
Management of hormone responsive diseases. Proceedings of the third international conference. June 7, 1986, Rotterdam, The Netherlands. Seminars in oncology, 1986, Volume: 13, Issue:4 Suppl 4 Topics: Breast Neoplasms; Female; Hormones; Humans; Megestrol; Megestrol Acetate; Neoplasms	1986
High-dose megestrol acetate in the treatment of postmenopausal women with advanced breast cancer. Seminars in oncology, 1986, Volume: 13, Issue:4 Suppl 4 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Humans; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Neoplasms, Hormone-Dependent	1986
Megestrol acetate: first-line therapy for advanced breast cancer. Seminars in oncology, 1986, Volume: 13, Issue:4 Suppl 4 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Female; Humans; Male; Megestrol; Megestrol Acetate; Middle Aged; Neoplasms, Hormone-Dependent; Retrospective Studies; Tamoxifen	1986
Appetite stimulation with megestrol acetate in cachectic cancer patients. Seminars in oncology, 1986, Volume: 13, Issue:4 Suppl 4 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Appetite; Body Weight; Breast Neoplasms; Cachexia; Drug Evaluation; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Prospective Studies; Regression Analysis	1986
High-dose megestrol acetate. A possible treatment for cachexia. JAMA, 1987, Mar-06, Volume: 257, Issue:9 Topics: Body Weight; Breast Neoplasms; Cachexia; Female; Humans; Male; Megestrol; Megestrol Acetate; Middle Aged	1987
Megestrol acetate therapy for advanced breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1985, Volume: 3, Issue:2 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Drug Evaluation; Female; Fluorouracil; Humans; Male; Megestrol; Megestrol Acetate; Menopause; Methotrexate; Receptors, Estrogen; Receptors, Progesterone	1985
Megestrol acetate in the treatment of advanced post-menopausal breast cancer. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 1986, Volume: 12, Issue:1 Topics: Aged; Body Weight; Breast Neoplasms; Carcinoma; Female; Humans; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Tamoxifen; Time Factors	1986
Mechanisms of action of progestational agents. Seminars in oncology, 1985, Volume: 12, Issue:1 Suppl 1 Topics: Breast Neoplasms; Cell Count; Cells, Cultured; Female; Humans; Megestrol; Megestrol Acetate; Progesterone; Progestins	1985
Use of megestrol acetate in advanced breast cancer on a single-daily-dose schedule. Seminars in oncology, 1985, Volume: 12, Issue:1 Suppl 1 Topics: Adult; Aged; Breast Neoplasms; Drug Administration Schedule; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Patient Compliance; Receptors, Estrogen	1985
Megestrol acetate v tamoxifen in advanced breast cancer in postmenopausal patients. Seminars in oncology, 1985, Volume: 12, Issue:1 Suppl 1 Topics: Adult; Aged; Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen	1985
Primary hormonal therapy of advanced breast cancer with megestrol acetate: predictive value of estrogen receptor and progesterone receptor levels. Seminars in oncology, 1985, Volume: 12, Issue:1 Suppl 1 Topics: Aged; Breast Neoplasms; Female; Humans; Male; Megestrol; Megestrol Acetate; Middle Aged; Receptors, Estrogen; Receptors, Progesterone	1985
Sequential treatment of metastatic breast cancer with tamoxifen after megestrol acetate therapy and vice versa (a retrospective study). Medical oncology and tumor pharmacotherapy, 1985, Volume: 2, Issue:2 Topics: Administration, Oral; Breast Neoplasms; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Megestrol; Megestrol Acetate; Neoplasm Metastasis; Prognosis; Tamoxifen	1985